Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Tumor, Adult: Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00005856
What this trial is testing

Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 59
Not applicableStudy completedNCT00253669
What this trial is testing

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System TumorsThromboembolism
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 110
Not applicableStudy completedNCT01009307
What this trial is testing

Study of Blood and Cheek Cell Samples From Patients With Glioma

Who this might be right for
Brain and Central Nervous System Tumors
University of California, San Francisco 1,709
Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00110032
What this trial is testing

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+24 more
National Cancer Institute (NCI) 46
Very early researchActive Not RecruitingNCT03893487
What this trial is testing

Fimepinostat in Treating Brain Tumors in Children and Young Adults

Who this might be right for
Diffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
Sabine Mueller, MD, PhD 30
Early research (Phase 1)Study completedNCT02101905
What this trial is testing

Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Oligodendroglioma+4 more
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Ended earlyNCT01095094
What this trial is testing

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Who this might be right for
Brain TumorAnaplastic AstrocytomaAnaplastic Ependymoma+6 more
Case Comprehensive Cancer Center 19
Early research (Phase 1)Study completedNCT00387933
What this trial is testing

Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 37
Testing effectiveness (Phase 2)Study completedNCT00003456
What this trial is testing

Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme of Brain
Burzynski Research Institute 40
Early research (Phase 1)Study completedNCT00002754
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer
Duke University 6
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT00616005
What this trial is testing

Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide

Who this might be right for
Glioblastoma
Duke University 41
Early research (Phase 1)Study completedNCT00005951
What this trial is testing

Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT00387894
What this trial is testing

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Brain Tumors
Michael Prados 6
Testing effectiveness (Phase 2)Ended earlyNCT00365222
What this trial is testing

Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
H. Lee Moffitt Cancer Center and Research Institute 1
Testing effectiveness (Phase 2)Ended earlyNCT00068770
What this trial is testing

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Not applicableNot Yet RecruitingNCT06845020
What this trial is testing

CSF Proteomic Characterization of Glioblastomas

Who this might be right for
GlioblastomaGlioblastoma WHO Grade IVGlioblastoma (GBM)+2 more
Univeridad Autonoma de Guadalajara 15
Not applicableLooking for participantsNCT06283927
What this trial is testing

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma, IDH-wildtype+5 more
Jasper Gerritsen 464
Testing effectiveness (Phase 2)Study completedNCT00553150
What this trial is testing

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 122
Next Page